Novo Nordisk
NVO
548 hedge funds and large institutions have $11.7B invested in Novo Nordisk in 2015 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 192 increasing their positions, 192 reducing their positions, and 34 closing their positions.
577% more call options, than puts
Call options by funds: $34.8M | Put options by funds: $5.14M
88% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 34
19% more funds holding in top 10
Funds holding in top 10: 32 → 38 (+6)
6% more capital invested
Capital invested by funds: $11B → $11.7B (+$691M)
4% more funds holding
Funds holding: 525 → 548 (+23)
0% more repeat investments, than reductions
Existing positions increased: 192 | Existing positions reduced: 192
0.11% less ownership
Funds ownership: 19.75% → 19.64% (-0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$77.3M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$56.2M |
| 3 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$33M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$26.7M |
| 5 |
WI
WBI Investments
Red Bank,
New Jersey
|
+$26.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$178M |
| 2 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$59.1M |
| 3 |
Lazard Asset Management
New York
|
-$21.6M |
| 4 |
SI
Scout Investments
Kansas City,
Missouri
|
-$21.5M |
| 5 |
Bank of New York Mellon
New York
|
-$19.9M |
NVO Hedge Fund Activity: Q4 2015 in Review
548 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2015, worth a combined $11.7B — up 6.3% from $11B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new NVO positions and 34 closed out — a net gain of 30 holders — while 192 added to existing stakes and 192 trimmed.
The largest buyer was WCM Investment Management, adding an estimated $77.3M. The largest seller was Jennison Associates, cutting an estimated $178M.
- 548 institutional investors held Novo Nordisk (NVO) as of Q4 2015, up from 525 in Q3 2015.
- Funds reported $11.7B of Novo Nordisk stock for Q4 2015, up 6.3% quarter-over-quarter.
- 64 funds opened new Novo Nordisk positions in Q4 2015 and 34 closed out, a net change of +30 holders.
- The largest Novo Nordisk buyer in Q4 2015 was WCM Investment Management, an estimated $77.3M added.
- The largest Novo Nordisk seller in Q4 2015 was Jennison Associates, an estimated $178M sold.
Based on aggregated 13F filings for Q4 2015.